from Gemini What does "Considered and Advised" actually mean?
When the CHM "considers and advises," it marks the end of the scientific review. They have looked at the Phase 3 trial data, the manufacturing safety, and the "Risk Management Plan."
If the advice was positive: The MHRA typically issues the formal license (Marketing Authorisation) within 30 to 67 days.
If the advice was negative: The company is usually given a chance to appeal or the application is withdrawn.
Summary Table: DCVax-L Status (Late 2025)
Category Status Drug Name DCVax-L (an autologous dendritic cell vaccine) Manufacturer Northwest Biotherapeutics (NW Bio) Target Newly diagnosed and recurrent Glioblastoma Review Stage Final CHM Advice (Nov 2025) Expected Outcome Formal MHRA decision likely in early 2026
Market Data 
Markets 
AI
